학술논문

890PEverolimus as first-line or after cytokine therapy in patients with metastatic recurrent and/or unresectable renal cell carcinoma (RCC) (EVERMORE).
Document Type
Article
Source
Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.
Subject
*RENAL cell carcinoma
Language
ISSN
0923-7534